MedPath

ow dose dexmedetomidine inhibit post operative nausea and vomitting and shivering post brain tumor resection. Double Blind Randomized Control Trial

Not Applicable
Conditions
Brain tumor
Registration Number
JPRN-UMIN000019139
Lead Sponsor
Yokohama City University Department of Anesthesiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

under 18 years old, not obtained informed consent, transferred to ICU under ventilation, insufficient data.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the incidence of PONV.
Secondary Outcome Measures
NameTimeMethod
The incidence of shivering and the variation of hemodynamics changes
© Copyright 2025. All Rights Reserved by MedPath